No Detail Found!

Efficacy of intralesional injection of platelet rich plasma in patients of de quervain's tenosynovitis

Author(s)
Rehan Wani Ghurki Trust Teaching Hospital, Lahore, Pakistan
Umbreen Aslam Ghurki Trust Teaching Hospital, Lahore, Pakistan
Rabnawaz Khan Ghurki Trust Teaching Hospital, Lahore, Pakistan
Muhammad Uzair Naru Ghurki Trust Teaching Hospital, Lahore, Pakistan
Ashfaq Ahmed Ghurki Trust Teaching Hospital, Lahore, Pakistan
Rizwan Akram Ghurki Trust Teaching Hospital, Lahore, Pakistan
Amer Aziz Ghurki Trust Teaching Hospital, Lahore, Pakistan
Abstract
Introduction: De Quervain's tenosynovitis is a disorder of the tendons of the fi rst dorsal compartment of the wrist that causes pain and functional disability, which may be refractory to conservative treatments. Platelet-rich plasma (PRP) has become increasingly popular in sports Medicine and Orthopaedic practice as treatment for muscle, tendon, and ligament injuries, and has received media at ention because of its promise as a regenerative therapy. Objective: To determine the efi cacy of intralesional injection of platelet rich plasma (PRP) in patients of De Quervain's tenosynovitis Material & Methods: Th is descriptive series were conducted at Department of Orthopedics and Spine centre, Ghurki Trust Teaching Hospital, Lahore Pakistan from January 2018 to July 2019. Total 100 patients fulfi lling the inclusion criteria were included in the study. Platelet rich plasma was obtained aft er centrifuging the blood taken from the patient. Under aseptic measures a phlebotomist obtained blood in vacutainer. Vacutainer was centrifuged and middle zone containing platelet rich plasma was aspirated in a 5 ml disposable syringe. Th e patient received intralesional injection plus oral non-steroidal anti-infl ammatory drug. hT e included patients were evaluated three weeks aft er treatment initiation for pain relief. Time of start of symptoms for more than one year and history of diabetes was treated as ef ect modifi er along with age and gender. Results: Mean age of patients was 41.26±11.26 years. Th ere were 53(53%) patients in the study who were diabetic. Efi cacy of treatment was seen in 85(85%) patients. However in 15(15%) patients Intralesional injection of platelet rich plasma was not ef ective. Efi cacy of treatment was not signifi cantly associated with age, gender, diabetes status and duration of symptoms. Conclusion: Keeping in mind the results of this study and as well as the results of pilot study conducted prior to this study intralesional injection of platelet rich plasma can be ef ectively used for de Quervain's tenosynovitis. However further studies are needed to put this treatment modality in the fi rst line treatment options for patients with de Quervain's tenosynovitis
Publication Details
Page(s) 14-19
DOI DOI not available
Published Journal: Pakistan Journal of Surgery, Volume: 37, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Intralesional, de Quervain's tenosynovitis, Injection, Platelet rich plasma, Efi cacy
0

Citations

0

Downloads

93

Views